|
시장보고서
상품코드
2091544
조직병리학 서비스 시장 규모, 점유율, 성장 분석 : 서비스 유형별, 용도별, 검체 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Histopathology Services Market Size, Share, and Growth Analysis, By Service Type (Tissue Processing & Staining, Biopsy Evaluation), By Application, By Sample Type, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 조직병리학 서비스 시장 규모는 2024년에 195억 달러로 평가되었으며, 2025년 211억 달러에서 2033년까지 396억 4,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.2%로 성장할 것으로 전망됩니다.
세계 조직병리학 서비스 시장은 특히 암 진단 및 치료에서 병리학이 수행하는 지극히 중요한 역할에 힘입어 눈부신 성장을 이루고 있습니다. 북미와 유럽 등 지역에서 암 유병률이 증가하고 고령화가 진행되고 있는 것이, 상세한 조직 분석에 대한 수요를 뒷받침하고 있습니다. 자동 조직 처리 장치나 면역조직화학 패널 등의 기술적 진보로 인해 서비스의 복잡성이 높아지고 있습니다. 전 슬라이드 이미징의 도입은 원격 사례 검토를 용이하게 하며, 이 분야의 디지털화 발전에 기여하고 있습니다. AI를 활용한 디지털 병리 플랫폼의 통합은 워크플로우를 혁신하고, 진단 정확도를 높이며, 검사 결과의 신속화와 비용 절감을 실현하고 있습니다. 그 결과, 병원들은 전문 서비스 제공업체에 대한 아웃소싱을 확대하고 있으며, 고급 분석 및 원격 병리학 시장의 규모와 매출이 크게 증가하고 있습니다.
세계 조직병리학 서비스 시장의 성장요인
세계 조직병리학 서비스 시장은 특히 암 진단 건수의 증가를 배경으로, 임상의들이 표적 치료 계획을 수립하는 데 있어 조직병리학에 대한 의존도가 높아지고 있는 점에 크게 영향을 받고 있습니다. 이러한 수요 증가에 따라 검사실은 서비스 내용을 강화하고 첨단 염색 기술을 도입하고 있으며, 이것이 시장 확대를 뒷받침하고 있습니다. 또한, 종양의 정확한 분류가 필요함에 따라 보조 검사의 이용이 증가하고 있으며, 이로 인해 전 세계 다양한 의료 시스템에서 조직병리학 서비스에 대한 전반적인 수요가 더욱 높아지고 있습니다. 또한, 상세한 병리 보고서는 규제 당국에서도 임상적으로 필수적인 것으로 인식되고 있으며, 병원이 전략적 계획을 수립하는 데 있어 중요한 고려 사항이 되고 있습니다.
세계 조직병리학 서비스 시장의 제약요인
세계 조직병리학 서비스 시장은 고해상도 스캐너, 자동 염색 시스템, 첨단 영상 처리 소프트웨어 등 첨단 기술을 도입하는 데 막대한 자금이 필요하기 때문에 큰 과제에 직면해 있습니다. 많은 병리 검사실, 특히 개발도상국에서는 예산 제약으로 인해 이러한 필수 장비에 대한 투자가 저해되고 있습니다. 그 결과, 이러한 기관들은 비효율적이고 시간이 많이 소요되는 구식 수작업 절차에 계속 의존하게 되어, 결국 조직병리학 서비스의 전반적인 효율성을 저하시킬 우려가 있습니다. 이러한 재정적 장벽이 최신 솔루션의 광범위한 도입을 제한하고 있으며, 임상 분야에서 전 세계적으로 수요가 증가하고 있음에도 불구하고 시장 성장을 저해하는 요인이 되고 있습니다.
세계 조직병리학 서비스 시장의 동향
세계 조직병리학 서비스 시장에서는 AI를 활용한 진단 도입을 향한 뚜렷한 추세가 나타나고 있으며, 이는 기존의 조직병리학 업무 흐름에 혁명을 일으키고 있습니다. 인공지능을 도입함으로써 슬라이드 판독이 신속해지고 결과의 편차가 줄어드는 한편, 예측에 대한 인사이트도 향상됩니다. 검사 기관에서는 영상 분석의 자동화, 이상 징후 파악, 그리고 병리 전문의의 복잡한 사례 관리 지원을 가능하게 하는 AI 플랫폼에 대한 투자가 점점 더 늘어나고 있습니다. 이러한 기술적 진보는 검사 결과 보고까지 걸리는 시간을 단축할 뿐만 아니라, 원격 보고 및 공동 연구 활동도 지원하고 있어, AI를 정밀 의학의 기반이 되는 요소로 효과적으로 자리매김하고 있습니다. 그 결과, 이러한 추세는 지속가능한 성장을 촉진하고 있으며, 전 세계의 학술 및 상업 병리 센터에서 서비스 포트폴리오의 확대로 이어지고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 조직병리학 서비스 시장 규모 : 서비스 유형별
세계의 조직병리학 서비스 시장 규모 : 용도별
세계의 조직병리학 서비스 시장 규모 : 샘플 유형별
세계의 조직병리학 서비스 시장 규모 : 최종사용자별
세계의 조직병리학 서비스 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.23Global Histopathology Services Market size was valued at USD 19.5 Billion in 2024 and is poised to grow from USD 21.1 Billion in 2025 to USD 39.64 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).
The global histopathology services market is experiencing significant growth driven by the critical role of pathology in disease diagnosis and treatment, particularly for cancer. The rising prevalence of cancer and the aging population in regions like North America and Europe have spurred demand for detailed tissue analysis. Technological advancements, including automated tissue processors and immunohistochemistry panels, are enhancing service complexity. The introduction of whole-slide imaging facilitates remote case reviews, contributing to a digital evolution in the field. The integration of AI-driven digital pathology platforms is transforming workflows and enhancing diagnostic precision, allowing for faster turnaround times and reduced costs. Consequently, hospitals are increasingly outsourcing to specialized service providers, resulting in a substantial increase in market volumes and revenues for advanced analytics and telepathology.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Histopathology Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Histopathology Services Market Segments Analysis
Global histopathology services market is segmented by service type, application, sample type, end user and region. Based on service type, the market is segmented into tissue processing & staining, biopsy evaluation, immunohistochemistry (IHC) services, digital pathology services, molecular pathology services and others. Based on application, the market is segmented into oncology diagnosis, infectious disease diagnosis, neurological disorders, gastrointestinal disorders, dermatopathology and others. Based on sample type, the market is segmented into tissue biopsies, surgical specimens, cytology samples and others. Based on end user, the market is segmented into hospitals, diagnostic laboratories, academic & research institutes and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Histopathology Services Market
The Global Histopathology Services market is significantly influenced by the rising reliance of clinicians on histopathology to inform targeted treatment plans, particularly in light of the increasing number of cancer diagnoses. This heightened demand is prompting laboratories to enhance their service offerings and adopt advanced staining technologies, thereby fueling market expansion. Furthermore, the necessity for precise tumor classification is leading to an increased utilization of ancillary tests, which further amplifies the overall requirement for histopathology services across various healthcare systems globally. Thorough pathology reports are also recognized as clinically essential by regulatory bodies, making them a crucial consideration for hospitals in their strategic planning endeavors.
Restraints in the Global Histopathology Services Market
The Global Histopathology Services market faces significant challenges due to the substantial capital required for acquiring advanced technologies such as high-resolution scanners, automated staining systems, and complex imaging software. Many pathology laboratories, particularly in developing regions, struggle with budget limitations that hinder investments in these essential tools. As a result, these institutions may continue to depend on outdated manual processes, which are often inefficient and time-consuming, ultimately decreasing the overall efficiency of histopathology services. This financial hurdle restricts the widespread implementation of modern solutions, creating a barrier to market growth despite an increasing global demand in the clinical sector.
Market Trends of the Global Histopathology Services Market
The Global Histopathology Services market is witnessing a significant trend towards the adoption of AI-powered diagnostics, which is revolutionizing traditional histopathology workflows. The incorporation of artificial intelligence facilitates faster slide interpretation and diminishes variability in results, while also providing enhanced predictive insights. Laboratories are increasingly investing in AI platforms capable of automating image analysis, identifying anomalies, and assisting pathologists with complex case management. This technological advancement not only reduces turnaround times but also supports remote reporting and collaborative research efforts, effectively positioning AI as a fundamental component of precision medicine. Consequently, this trend is fostering sustainable growth and expanding service portfolios across academic and commercial pathology centers worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Customer & Buying Criteria Analysis
Global Histopathology Services Market Size by Service Type & CAGR (2026-2033)
- Market Overview
- Tissue Processing & Staining
- Biopsy Evaluation
- Immunohistochemistry (IHC) Services
- Digital Pathology Services
- Molecular Pathology Services
- Others
Global Histopathology Services Market Size by Application & CAGR (2026-2033)
- Market Overview
- Oncology Diagnosis
- Infectious Disease Diagnosis
- Neurological Disorders
- Gastrointestinal Disorders
- Dermatopathology
- Others
Global Histopathology Services Market Size by Sample Type & CAGR (2026-2033)
- Market Overview
- Tissue Biopsies
- Surgical Specimens
- Cytology Samples
- Others
Global Histopathology Services Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Global Histopathology Services Market Size & CAGR (2026-2033)
- North America (Service Type, Application, Sample Type, End User)
- US
- Canada
- Europe (Service Type, Application, Sample Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Service Type, Application, Sample Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Service Type, Application, Sample Type, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Service Type, Application, Sample Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratory Corporation of America Holdings (Labcorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sonic Healthcare Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synlab AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeoGenomics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Unilabs Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PathGroup, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inform Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ARUP Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayo Clinic Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fulgent Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Exact Sciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cerba HealthCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioReference Health, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HCA Healthcare, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DaVita Inc. (Pathology Services Division)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medicover AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SRL Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Metropolis Healthcare Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
